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Abstract
The eukaryotic XPD helicase is an essential subunit of TFIIH involved in both transcription and nucleotide excision repair
(NER). Mutations in human XPD are associated with several inherited diseases such as xeroderma pigmentosum, Cockayne
syndrome, and trichothiodystrophy. We performed a comparative analysis of XPD from Homo sapiens and Chaetomium
thermophilum (a closely related thermostable fungal orthologue) to decipher the different molecular prerequisites necessary
for either transcription or DNA repair. In vitro and in vivo assays demonstrate that mutations in the 4Fe4S cluster domain of
XPD abrogate the NER function of TFIIH and do not affect its transcriptional activity. We show that the p44-dependent
activation of XPD is promoted by the stimulation of its ATPase activity. Furthermore, we clearly demonstrate that XPD
requires DNA binding, ATPase, and helicase activity to function in NER. In contrast, these enzymatic properties are
dispensable for transcription initiation. XPD helicase is thus exclusively devoted to NER and merely acts as a structural
scaffold to maintain TFIIH integrity during transcription.
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Introduction
The human XPD protein is a helicase with 59–39 polarity [1,2]
that contains a 4Fe4S cluster (FeS) [3–6] and is organized within
the context of the general transcription factor IIH (TFIIH). TFIIH
consists of a total of 10 subunits of which XPB, p62, p52, p44, p34,
and p8 build the core and cdk7, MAT1, and cyclin H comprise an
additional regulatory unit called the CAK complex; both
subcomplexes are bridged by XPD [7–10]. The first assigned
function of TFIIH was its role as a basal transcription factor
promoting RNA polymerase II (RNAPII)–based transcription
[10–13]. Within this process, TFIIH participates in initiation,
promoter escape, and the early elongation steps [9,14–18]. Later it
has been shown that TFIIH is also involved in RNA polymerase I–
and probably III–based transcription [8,19]. While the TFIIH
core assumes responsibility for promoter opening, the CAK
subcomplex promotes initiation and elongation through phos-
phorylation of the C-terminal domain (CTD) of the Rbp1 subunit
of RNAPII. In addition, it has been shown that CAK is also
responsible for the transactivation of nuclear receptors.
Next to its function in transcription, TFIIH plays a major role
in eukaryotic nucleotide excision repair (NER) [10,20–22]. NER
is the most versatile DNA repair pathway due to its ability to
remove bulky lesions, as well as smaller lesions such as cisplatin
adducts or photoproducts caused by ultraviolet light [23–26]. In
NER, TFIIH is recruited to the site of damage by the XPC–
HR23B complex after initial damage recognition has been
achieved [23,27–29]. At this point, TFIIH is of vital importance
for damage verification and the procession of the NER cascade
resulting in the excision of the damaged DNA fragment. The
significance of TFIIH within the repair cascade is reflected in its
association with three severe hereditary human diseases: xero-
derma pigmentosum (XP), Cockayne syndrome (CS), and
trichothiodystrophy (TTD). It is interesting to note that TTD
patients seem to be also affected partly in aspects of transcription
[26,30,31]. In the context of human diseases, it is particularly
noteworthy that mutations causing XP, CS, or TTD can be
located on a single gene, namely XPD [1,32], that also harbors
most of the described mutations that are associated with TFIIH.
It has been enigmatic for a long time how these very different
phenotypes can be associated with a single gene. Recent crystal
structures of archaeal XPD homologues shed some light on this
puzzling matter. The structures revealed that XPD contains four
domains (Figure 1), of which two are canonical RecA-like
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domains (helicase domains 1 and 2, HD1 and HD2), and two
additional domains that are inserted in HD1, a so-called Arch
domain and a domain harboring the FeS cluster [3,5,6,23].
XPD as well as XPB belong to superfamily 2 (SF2) helicases but
operate with opposite polarities [7,9,10,33]. In addition, the roles
of XPD and XPB in transcription and repair seem to differ
significantly [10,34]. The helicase activity of XPB is required for
promoter opening and promoter escape after the preinitiation
complex (PIC) has been assembled [9,16,17,26,35]. In NER only
the ATPase activity of XPB is necessary to anchor TFIIH to the
lesion site [19,26,32], whereas its helicase activity seems to be
dispensable [10,19,25]. In contrast, XPD is a vital factor for NER,
including its helicase activity [23,25,26,36]; XPD is interacting
(Figure 1) with the p44 subunit within the TFIIH core and with
the MAT1 subunit of the CAK complex [23,28,37]. Whereas p44
binds to the very C terminus of XPD [4,6,26,37,38], MAT1 is
recruited via the Arch domain [23,32]. It has been shown that p44
is able to stimulate the helicase activity of XPD [5,6,23,37] and
that the interaction with CAK negatively regulates the helicase
activity of XPD [33,37]. For transcription, however, it is less clear
which of the XPD activities are required. Early work in yeast has
shown that a temperature-sensitive mutant of Rad3, the XPD
ortholog in yeast, is affected in transcription [34,39]. It has also
been shown that TTD-inducing XPD mutations that abolish the
interaction with p44 have an impact on the transcriptional
properties of TFIIH [9,22,26]. Furthermore, mutations in the
Arch and FeS domains cause a TTD phenotype and show
decreased transcriptional activity [26,32]. In contrast, the Walker
A motif variant K48R, which displays no ATPase and helicase
activities, supports transcription [19,25,26].
In this study, we have used a combinatorial approach of
characterizing two eukaryotic XPD proteins to delineate which of
its properties and domains are dedicated to transcription and
NER. We show that the FeS domain of XPD is crucial for NER.
In addition, our results clearly demonstrate that the repair process
depends on XPD’s biochemical and enzymatic properties for
successful NER, thus requiring DNA binding, ATPase activity,
helicase activity, as well as the correct interaction with other
TFIIH subunits. In stark contrast, all enzymatic properties
including DNA binding are not essential for the different steps
in transcription; here, XPD only acts as a scaffold within TFIIH
with the sole requirement to support protein–protein interactions.
Results
Comparative Mutagenesis of Human and Fungal XPD
Proteins from the fungus Chaetomium thermophilum provide an
ideal basis to perform biochemical studies, as they are closely
related to their human homologues but are significantly more
stable and thus amenable to purification [36,40]. We employed a
comparative functional mutagenesis study of C. thermophilum
XPD (ctXPD) and human XPD (hsXPD). The sequence
alignment (Figure S1a) shows that ctXPD and hsXPD are closely
related with a relative homology of 74% and an identity of 55% (as
defined by Blast). Based on the sequence alignment, homology
modeling, and previous studies on Thermoplasma acidophilum
XPD (taXPD) [37,41–43], we chose the following variants to be
generated in hsXPD and ctXPD: hsC134S/ctC133S, hsY158A/
ctY156A, hsF193A/ctF192A, hsR196A/ctR195A, hsR196E/
ctR195E, and hsR722W/ctK719W, of which five residues are
identical and the remaining is type-conserved. The variants
include a TTD mutation (hsR722W/ctK719W) and point
mutations that have been shown to be of functional significance
in archaeal homologs of XPD (Figure S1a,b and Table 1). In
addition, we generated the ctK48R variant, which disrupts the
Walker A motif and thus ATP hydrolysis of XPD in C.
thermophilum, to serve as a negative control. We focused on
variants located in the N-terminal domain of XPD—that is, the
FeS domain—as it has been implicated as being highly important
for archaeal XPD function [4,6,28,37,38]. To further analyze
hsXPD, we introduced three additional variants. HsL372A was
generated to test whether a mutation in the Arch domain, which is
most likely not involved in DNA binding, ATPase activity, and
helicase activity, would affect the function of hsXPD. In addition
to hsC134S/ctC133S, the variant hsC155S was designed to
further probe the FeS cluster of hsXPD (both Cys134 and Cys155
coordinate the FeS), and hsF161A as an alternative residue for the
corresponding ctY156A variant (see Figure S1a). None of the
ctXPD variants affected its overall fold, as they could be expressed
and purified to at least 95% homogeneity, with the exception of
the ctC133S variant (Figure S2a) and the analysis by CD
spectroscopy showed that the wild-type protein and all variants
display similar CD spectra (Figure S2b).
Interaction of ctXPD with ctp44
To fully exploit our ctXPD model system, we also cloned and
expressed C. thermophilum p44 (ctp44) comprising residues 1–285.
This construct is analogous to an hsp44 construct that is fully
capable of activating hsXPD [8,23] but lacks the C-terminal Ring
and Zn-finger domains of p44. Size exclusion chromatography
(SEC) experiments revealed that equimolar ratios of ctXPD and
ctp44 form a stable complex exemplified by a significant shift in
the elution volume of a single peak representing the ctXPD–ctp44
complex, which can be clearly distinguished from the peaks of the
single proteins (Figure 2a). In contrast, the ctR719W variant,
which corresponds to the human R722W variant that abrogates
the p44 interaction with hsXPD, displays no shift, thus clearly
indicating the impairment of complex formation (Figure 2b). We
then investigated all ctXPD variants for complex formation with
ctp44 and observed ctXPD/ctp44 wild-type–like complex forma-
tion for all other variants, thus indicating that none of the other
mutations interfered with p44 interaction (Figure S2c).
ssDNA Binding of ctXPD Variants
We assessed the ssDNA binding properties of ctXPD and its
variants (Figure 2c and Table 2). The wild-type protein displayed
a dissociation constant (KD) of 118 nM, which was not altered in
Author Summary
The multiprotein complex TFIIH is crucially involved in two
fundamental cellular processes—the transcription of genes
by RNA polymerase II and the repair of UV-induced DNA
damage by a mechanism called nucleotide excision repair
(NER). The xeroderma pigmentosum complementation
group D (XPD) helicase, which is mutated in the
eponymous human photosensitivity and cancer syndrome,
is an important subunit of TFIIH, where it is assumed to act
as a helicase, unwinding the DNA double helix. In our
study, we show that XPD assumes an entirely different role
in transcription and NER. In the case of repair, this protein
works as an enzyme, requiring all its known functional
properties. For transcription, however, none of the
enzymatic functions is essential and XPD switches from
an enzyme to a structural protein whose job is merely to
preserve the integrity of the TFIIH complex. We have
shown thus that the helicase activity of the XPD protein is
exclusively devoted to repair processes and could be
targeted by drugs without affecting transcription.
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the presence of p44 (95 nM); hence, we omitted p44 from the
analysis of the variants. The affinity of ctXPD to ssDNA is very
comparable to the affinity of the archaeal homologues
[5,6,37,38,44]. The ctK48R and ctK719W variants display no
major alteration in affinity for ssDNA with KD values of 159 nM
and 192 nM, respectively. Because the ctK48R variant contains a
mutation in the helicase Walker A motif that is solely responsible
for ATP hydrolysis, the results are in line with the role of this
motif. The ssDNA affinity of ctK719W clearly shows that DNA
binding is not affected, implying that the deficiency to interact with
p44 impairs XPDs helicase activity by other means; this is in line
with the fact that p44 does not influence the affinity of ctXPD for
ssDNA. All other ctXPD variants are significantly impaired with
respect to their ability to bind to ssDNA, with KD values ranging
from 561 nM to 1,035 nM (Table 2), which is in agreement with
their proposed proximity to the DNA path along the XPD
molecule [37,38].
ssDNA-Dependent ATPase Activity of ctXPD Variants
Due to the possibility to express functional fungal XPD and p44
separately, we first analyzed whether the ctXPD ATPase activity is
dependent on p44 activation. Surprisingly, we observed a clear
p44-related effect. The activity increased from 0.12 mol ATP?mol
XPD21?s21 to 0.7 mol ATP?mol XPD21?s21 after adding ctp44
to ctXPD in a 2:1 molecular ratio (Figure 2d and Table 2).
Because the ssDNA affinity of XPD itself is not altered by p44
binding, p44 must directly activate the ATPase function of XPD.
As expected, the ctK48R Walker A variant is ATPase deficient.
The decreased affinity for ssDNA in the ctY156A variant leads to a
reduced activation of the ATPase activity, with 61% of wild-type
activity. Surprisingly, the ctF192A variant that bound to ssDNA
with a 6-fold increase in KD (Figure 2c) only displayed 27% of
wild-type ATPase activity. Inferred from the structures of archaeal
XPDs [37], this residue is not involved in ATP binding; thus, F192
may participate in an ATP hydrolysis-mediated helicase step on
the translocated ssDNA using base stacking interactions [4–6,39].
The impaired translocation on ssDNA could disturb the concerted
action of HD1 and HD2 during ssDNA-dependent ATP
hydrolysis and provides a likely explanation for its strongly
reduced ATPase activity. The two variants R195E/A displayed an
approximately 10-fold decrease in affinity for ssDNA. Whereas the
ATPase activity of R195A was only moderately affected with a
decrease to 54% compared to wild-type ctXPD, ctR195E is even
further reduced and displayed only 20% residual activity. The p44
Figure 1. XPD and its partners in TFIIH. Schematic representation of XPD and its interaction partners p44 and MAT1 within the CAK complex of
TFIIH. XPD from taXPD in the center is shown with the two helicase domains (HD1 and HD2) in yellow and red, respectively, with the FeS cluster-
containing domain in cyan and the Arch domain in green. P44, which interacts with the C-terminal end of XPD, is shown in pale green. The CAK
complex, which interacts with XPD via the MAT1 subunit, is shown in different blue colors.
doi:10.1371/journal.pbio.1001954.g001
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interaction-deficient ctK719W variant displayed a highly de-
creased ATPase activity reflecting the basal ctXPD ATPase level
in the absence of p44, thus further supporting the notion that p44
directly stimulates XPD’s ATPase activity. All other variants
displayed a significant decrease in p44-dependent ATPase activity,
which can be explained by their reduced DNA binding ability, as
ssDNA is necessary to trigger XPD’s ATPase activity.
Helicase Activity of XPD Variants
To investigate the influence of the XPD mutations on the
helicase activity of XPD, we performed in vitro helicase assays
with ctXPD and hsXPD in the presence and in the absence of p44
(see Materials and Methods, Figure 3a,b, and Table 2). In the
absence of ctp44, no significant unwinding by ctXPD could be
detected. In the presence of ctp44, wild-type ctXPD was readily
unwinding the 59 overhang substrate and yielded an activity of
1,906.3 DFl.?s21, indicating a robust 59–39 polarity (Figure 3). The
walker A motif mutant ctK48R, which is unable to hydrolyze
ATP, also failed to separate dsDNA (7.8 DFl.?s21). The ctK719W
variant was also highly affected in its helicase activity (4.8
DFl.?s21), due to its loss of p44 interaction, resulting in a highly
decreased ATPase activity. The ctF192A and ctR195A/E variants
that were impaired in DNA binding and ATPase activity were
highly deficient with respect to their p44-dependent helicase
activity, with values of 8.6 DFl.?s21, 24.1 DFl.?s21, 9.3 DFl.?s21,
and 11.2 DFl.?s21, respectively. Because the loss of helicase activity
cannot be explained by the lack of p44 interactions, these data
substantiate the role of these residues in DNA binding, which
subsequently affects the ATPase and helicase activities of XPD.
The only variant displaying notable p44-dependent helicase
activity was ctY156A, with an approximately 5-fold reduction in
activity, thus still being significantly impaired.
We analyzed the helicase activity of the hsXPD variants with an
in vitro assay that detects the displacement of a 32P-labeled DNA
fragment previously annealed to a single-stranded circular DNA
[22,26]. Upon interaction with p44, hsXPD exhibited a high and
significant 59–39 helicase activity (Figure 3b, lanes 2–3 and the
histogram below), whereas the hsR722W variant was not
stimulated by p44 (lane 12) due to the loss of p44 interaction
(Figure S3c) [23,26], as also observed for the corresponding
proteins from C. thermophilum (Figure 2b). All other variants
displayed a strongly diminished helicase activity. Notably,
hsF161A, which was chosen as a possible alternative for ctY156A,
showed highly impaired helicase activity, indicating its functional
importance. Curiously, hsC134S, the counterpart to ctC133S,
seems to behave more stably than its fungal homologue, which
exhibited an altered expression profile (Figure S2a). However,
even though the expression behavior of hsC134S was comparable
to wild-type hsXPD, it displayed no helicase activity, which is most
likely caused by affecting the overall stability of the FeS domain of
hsXPD. A similar explanation can be assumed for the other
variant targeting the FeS cluster, hsC155S, which also abolished
helicase activity. The only exception to the loss-of-function
variants was hsL372A, which displayed wild-type–like helicase
activity, confirming that this residue is not directly involved in
helicase activity.
Importantly, the helicase phenotypes observed for the hsXPD
variants are highly comparable to the phenotypes of the ctXPD
variants. Due to the strong correlation of the helicase phenotypes
in the human and the fungal system as well as the interaction
studies with p44 and the CAK subunits (see below), it is valid to
assume that the defects causing the deficiency in helicase activity
by the lack of ssDNA binding, ATPase activity, or p44 interaction
can be directly translated from ctXPD to hsXPD.
NER Properties of hsXPD Variants
To assess the ability to perform NER in vitro, a dual incision
assay was used in which hsXPD or its variants were added to
purified recombinant human core-TFIIH (rIIH6) (Figure 4a),
together with XPC-HR23B, XPA, RPA, XPG, ERCC1-XPF, and
a closed circular plasmid with a single 1,3-intrastrand d(GpTpG)
cisplatin-DNA crosslink [25,26,34]. In the absence of hsXPD, the
XPG and ERCC1-XPF endonucleases were unable to excise the
damaged DNA and liberate the damaged oligonucleotide with a
length of 23–25 nt (Figure 4b,c, compare lanes 1 to lanes 2 and 3).
All investigated hsXPD variants, with the exception of the L372A
variant, lacked the ability to catalyze successful NER within the
reconstituted rIIH complexes (Figure 4b,c). The activity of the
variants is comparable to that of the hsR722W mutation
(Figure 4c, lanes 12 and 13 and histogram). HsL372A behaves
indistinguishably from wild-type XPD, further supporting that this
residue is not relevant for NER activity.
A host cell reactivation assay was used to investigate the in vivo
repair capabilities of selected XPD variants. In this assay, the capacity
of XPD variants to repair and express a damaged gene in a cellular
context utilizing HD2 cells is measured. HD2 cells are NER-deficient,
resulting from the fusion between human fibroblasts harboring the
XPD/R683W point mutation and HeLa cells [32,40]. A plasmid
encoding the firefly luciferase gene was exposed to UVC radiation and
then transfected in combination with a second vector expressing
Table 1. List of ctXPD and hsXPD variants, their location, and properties.
Variant in C.
thermophilum
Variant in H.
sapiens
Structure
Element ssDNA Binding ATPase Helicase Transcription NER
K48R K48R HD1 + 2 2 + 2
C133S C134S FeS n.d. n.d. 2 + 2
— C155S FeS n.d. n.d. 2 + 2
Y156A Y158A, F161A FeS 2 2 2 + 2
F192A F193A FeS 2 2 2 + 2
R195A/E R196A/E FeS 2 2 2 + 2
— L372A Arch n.d. n.d. + + +
K719W R722W HD2 + 2 2 2 2
2, indicates impaired activity; +, activity; n.d., not determined.
doi:10.1371/journal.pbio.1001954.t001
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Renilla luciferase to normalize transfection efficiencies. A third vector
expressing the XPD variants was added to the cells (Figure 4d,e). The
firefly luciferase activity in cell lysates was measured 48 h posttransfec-
tion and normalized using wild-type activity as a reference.
Transfection of hsC134S, which exhibited almost no in vitro double
incision activity, did not permit the expression of the luciferase gene
after UV irradiation and exhibited an activity comparable to that of the
control transfected with an empty vector (Figure 4d, lanes 2 and 3).
However, hsR196A/E, which also showed reduced in vitro double
incision activity, partially permitted the expression of luciferase. The
nonirradiated control experiments showed a comparably high
expression activity in all cases (Figure 4e). These data demonstrate
that the XPD variants are defective in DNA repair both in vitro and in
vivo. The expression of the luciferase in the control experiment without
Figure 2. Functional analysis of ctXPD. (a) SEC of ctXPD wild type with ctp44 (1–285). Ctp44 (pink) and ctXPD (blue) were analyzed separately
and in a 1:1 stoichiometry (red) mixed prior to SEC. (b) SEC of the ctK719W variant with ctp44 (1–285). The color coding is chosen as in (a). (c) ssDNA
binding of ctXPD was analyzed by biolayer interferometry. Measurements were performed in triplicate and with different protein batches. (d) In vitro
ATPase assay of ctXPD wild type in the presence (black bars) and absence of ctp44 (1–285) (grey bar). Subsequently all variants were analyzed in the
presence of ctp44 (1–285). The data used to generate panels (c) and (d) have been deposited as supplementary information in xls format (Table S1).
doi:10.1371/journal.pbio.1001954.g002
Table 2. Biochemical parameters of ctXPD and variants.
Variant KD (nM) ssDNA
ATPase Activity XPD
(mol ATP?s
21
?mol
21 XPD)
KD (nM)+p44
ssDNA
ATPase Activity XPD+p44
(mol ATP?s
21
?mol
21 XPD)
Helicase Activity+p44 (Rel.
Fluorescence Change?s21)
Wild type 118637 0.1260.01 93616 0.7060.32 1,906.36408.9
K48R 159640 - - n.d. 7.866.7
Y156A 5616100 - - 0.4360.12 407.5670.1
F192A 6686107 - - 0.1960.10 24.167.1
R195E 9166257 - - 0.1560.07 9.367.2
R195A 1,0356193 - - 0.3860.07 11.264.3
K719W 192654 - - 0.1260.02 4.862.3
doi:10.1371/journal.pbio.1001954.t002
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UV irradiation was not affected, indicating regular transcription and
expression promoted by the XPD variants. To exclude the possibility
that the negative effects in repair are due to a disturbed CAK
interaction, we performed interaction studies of wild-type ctXPD and
its variants with ctMAT1 (residues 1–248) employing native PAGE
experiments. Figure S3a shows that all variants form a complex with
ctMAT1 in a wild-type–like manner, indicating no impairment in
CAK interaction (Figure S3a). In a parallel approach, we probed the
interaction of p44 and CAK with hsXPD, hsC134S, hsR722W, and
hsK48R using pull-down experiments (Figure S3b,c). Our data show
that hsC134S and hsK48R still interact with p44 and the CAK
complex. This is not the case when looking at hsR722W, which shows
an impairment in p44 interaction but not in CAK interaction. Our
data thus exclude the possibility that an interruption betweenXPD and
the CAK subcomplex leads to the altered NER phenotype of the
investigated XPD variants and the pull-down assays with p44 further
signify the similarity between hsXPD and ctXPD
In Vitro Transcriptional Activity of hsXPD Variants
We next investigated the transcriptional properties of the rIIH6
complexes in an in vitro reconstitution assay in which XPD
variants were added in increasing amounts to purified rIIH6 core
and CAK in addition to the recombinant basal transcription
factors TBP, TFIIA, TFIIB, TFIIE, TFIIF, as well as purified
endogenous RNAP II (Figure 5a). Surprisingly, most hsXPD
variants led to a transcriptional activity comparable to wild-type
XPD in terms of transcript length and amount, regardless of their
enzymatic impairment. The exceptions are the hsR722W (activity
of 20%63%) and, to a much lesser extent, the hsC134S (activity of
65%618%) variants. The transcriptional defect of hsR722W
(Figure 5a, lanes 33–35 and Figure 5b) can readily be explained
due to the lack of an interaction with p44 (Figure S3c). This
mutant also displayed the highest impairment of all variants.
HsC134S most likely constitutes a protein with a compromised
FeS domain that could affect its overall stability. Titration
experiments show that the effect on transcriptional activity of
hsC134S is only moderate as compared to other variants or
hsXPD (Figure 5b). However, although the FeS domain is
compromised, the protein clearly supported transcription, indi-
cating that the FeS domain is not vital for the transcription
function of XPD. In order to exclude that residual helicase activity
of some XPD variants is responsible for transcriptional activity, we
performed time course transcription experiments with selected
hsXPD variants. The data show that wild type and K48R show a
Figure 3. Helicase activity of ctXPD and hsXPD and its variants. (a) Helicase activity of wild-type ctXPD in the presence of ctp44 (1–285) and
its variants analyzed utilizing a fluorescence-based helicase assay. (b) hsXPD wild-type and variants were expressed in insect cells using the
baculovirus overexpression system and immunoprecipitated using an antibody (Ab) directed toward the Flag epitope fused at the N terminus of the
protein. After elution with the Flag synthetic peptide, equal amounts of purified proteins were resolved by SDS/PAGE with 12% (w/v) polyacrylamide
followed by Western blot (WB) analysis (upper panel, lanes 3 to 12). Bands shown in lanes 2 and 13 in the upper panel are a duplication of lanes 3
(wild type) and 11 (L372A). Purified XPD wild type and variants were added to a 59-strand extension probe in the presence of an excess of p44 to
evaluate their 59–39 helicase activity. The reaction was analyzed by electrophoresis on a 14% (w/v) polyacrylamide gel and analyzed by
autoradiography. Controls include reactions performed in the absence of wild-type XPD (lane 1) and in the absence of p44 (lane 2). The native and
denatured probes have also been analyzed (lanes 14 and 15, lower panel). The data used to generate panels (a) and (b) have been deposited as
supplementary information in xls format (Table S2).
doi:10.1371/journal.pbio.1001954.g003
Role of XPD in NER and Transcription
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similar increase over time, hsC134S shows a slightly affected
activity, whereas the hsR722W variant displays strongly reduced
activity (Figure S4). Because the Walker A mutant K48R and the
hsC134S variant only display background levels of helicase activity
but remain active in transcription, an effect of residual helicase
activity on transcription can be excluded.
To substantiate our results, we further analyzed the hyperpho-
sphorylation state of the carboxy terminal domain (CTD) of the
largest subunit (Rbp1) of RNAP II by the CAK subcomplex of
TFIIH that is supposed to be anchored to the core through an
interaction with XPD (Figure 5c), an important requirement for
the transition between initiation and promoter escape [3,5,6,41–
43]. The hyperphosphorylated form of RNAP II (IIO) was
prevalent in all variants and comparable to wild-type hsXPD,
demonstrating that RNAP II was capable of elongating normally.
The only exception here is the hsR722W variant that displayed
nearly no hyperphosphorylation activity (Figure 5c, lanes 10 and
11). Lastly, we analyzed the effect of increasing concentrations of
the CAK complex on the in vitro transcription activity (Figure 5d).
To this end, we selected the variants hsF193A and hsR722W.
While increasing amounts of the CAK complex stimulated the
activity of wild-type hsXPD and hsF193A, this stimulation was
substantially reduced when no XPD was present (Figure 5d, lanes
1 and 2). A similar phenotype was observed for hsR722W, which
also showed a significantly reduced transcription activity and
increasing amounts of CAK led to similar results, as observed in
the absence of XPD (Figure 5d, lanes 7 and 8). Because the
hsR722W variant is not impaired in the CAK interaction (Figure
S3b) [28,32], the recruitment of CAK by XPD must be disturbed
due to the lack of p44 interaction (Figure S3c), which impairs the
incorporation of XPD into the core TFIIH. This effect cannot be
rescued by addition of CAK in excess.
Discussion
Several studies have underlined the dual function of TFIIH in
both transcription and DNA repair (reviewed in [8]). However,
these very distinct tasks may require different roles/functionalities
for each of the 10 subunits and, in particular, for the two ATP-
dependent helicases XPB and XPD. We here focus on XPD and
its involvement in both processes, and demonstrate its specific and
exclusive role as an enzyme in DNA repair.
We chose a combinatorial approach that allowed us to dissect
functions of XPD by assessing the influence of the introduced
variants on the primary enzymatic properties such as DNA
binding, ATPase activity, helicase activity, and, in addition, on
Figure 4. NER activity of hsXPD and its variants. (a) Purified core-TFIIH (rIIH6) resolved by SDS-PAGE followed by Coomassie staining and
Western blot analysis. (b and c) NER activity of reconstituted TFIIH containing mutant XPD proteins. XPD wild type or variants (100 and 200 ng) were
mixed with purified core-TFIIH (rIIH6) and added to an in vitro double-incision assay using recombinant NER factors. The reaction was analyzed by
electrophoresis followed by autoradiography. Incision activities from three independent experiments were quantified and normalized to wild type. (d
and e) Host cell reactivation activity of XPD variants. HD2 fibroblasts were transfected with a reporter plasmid expressing firefly luciferase previously
exposed to 1,000 J/cm2 UVC-light (254 nm) (d) or with the nonirradiated control (e) in combination with vector expressing renilla luciferase to
normalize transfection efficiencies and pIERS2-EGFP expressing XPD wild-type or mutant proteins. The firefly luciferase activity in cell lysates (48 h
posttransfection), normalized with the internal renilla luciferase standard, assesses repair complementation. The values of three independent
experiments are presented as percentages, with 100% being the level of luciferase activity obtained with wild-type XPD. The data used to generate
panels (c), (d), and (e) have been deposited as supplementary information in xls format (Table S3).
doi:10.1371/journal.pbio.1001954.g004
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protein–protein interactions that are important for enzymatic
function. In a second step, these variants were investigated in NER
and transcription, to establish a relationship between a phenotype
and its underlying molecular cause in a TFIIH-dependent context.
We introduced mutations that especially cover the FeS domain of
XPD (Figure 1 and Figure S1), as this domain has been proposed
to be of importance for XPD function [37,38,44]. In addition, we
have chosen the disease-related variant R722W located at the C
terminus of XPD that disrupts the interaction with p44 and lastly
the Walker A motif variant K48R. Our analysis shows that ctXPD
and hsXPD are highly comparable with respect to their particular
enzymatic properties and that results obtained with ctXPD can be
Figure 5. Transcriptional activity of hsXPD and its variants. (a) Basal transcription activity. Increasing amounts of the recombinant XPD
variants (,50, 100, and 250 ng) were mixed with purified core-TFIIH (rIIH6) (250 ng) and CAK (300 ng) to an in vitro reconstituted transcription
system containing all the basal transcription factors and the AdMLP. Transcripts were analyzed by electrophoresis followed by autoradiography. The
length of the corresponding transcript is indicated on the right side. (b) Dose–response curves for XPD-wt and mutants C134S, F193A, R196A/E, and
R722W. We have selected the hsF193A and hsR196A/E variants that exhibited levels of transcription similar to wild-type hsXPD as a reference. The
transcription activity was estimated from densitometric analysis of autoradiograms (arbitrary units). The data are also plotted as % wild-type activity
in the panel to the right. (c) CTD phosphorylation of RNAP II by reconstituted TFIIH with XPD variants was analyzed by SDS-PAGE and followed by WB
detection. Purified core-TFIIH (250 ng), CAK (300 ng), and XPD variants (100 or 300 ng) were mixed in an in vitro assay containing all the basal
transcription factors and the AdMLP. Arrows indicate hypophosphorylated (IIA) and hyperphosphorylated (IIO) forms of RNAP II. (d) Transcription
activity of reconstituted TFIIH containing XPD variants (250 ng core-TFIIH and 200 ng XPD) was assessed in the presence of different amounts of
purified recombinant CAK (150 and 300 ng).
doi:10.1371/journal.pbio.1001954.g005
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readily extended to hsXPD. Therefore and for reasons of
simplicity, we will only mention the human XPD numbers of all
analyzed variants from here on.
All variants located in the FeS domain of XPD are impaired in
helicase activity, which is caused by different defects in singular
properties such as reduced DNA binding, ATPase activity, or the
inability to separate dsDNA. The highly altered DNA binding
ability observed in the R196E variant therefore leads subsequently
to diminished ATPase and helicase activity. An interesting
phenotype is, however, constituted by the Y158A variant.
Although it retains 61% ATPase activity compared to wild-type
XPD, the helicase activity is affected more than one would
anticipate based on the ATPase data. The position of this variant
in the structural model (Figure S1b) suggests that it could be
involved in duplex separation, which is predicted to take place at
the outer rim of the FeS domain [37,38]. The observed lack of
duplex unwinding would be a direct result of the inability to
separate dsDNA, thereby targeting the helicase function of XPD
without a major effect on ATPase activity. Because F161A is also
highly diminished in helicase activity and is located in close
proximity to Y158, it is tempting to speculate that a similar
phenotype for these variants is the likely explanation. Conse-
quently, the C134S and C155S variants directly targeting the
coordination of the FeS cluster in the FeS domain are also
impaired in their helicase activity, which is most likely due to
unfolding of the entire FeS domain [4–6]. Since the structural part
responsible for the separation of dsDNA is located in the FeS
domain, the unfolded FeS domain cannot mediate the separation
of dsDNA, resulting in an inactive helicase. In contrast, the Walker
A K48R variant interacts with DNA like the wild-type protein but
lacks ATPase activity and thereby causes an impaired helicase
activity. The p44 interaction-deficient R722W is helicase-deficient
due to an impaired interaction with p44. So far, however, it has
not been known how p44 activates XPD. We show here that p44
strongly activates the ATPase activity (and consequently the
unwinding activity) of XPD. This effect is not mediated by an
increase in affinity for ssDNA but through a direct up-regulation of
the ATPase motor activity of XPD via a yet unknown mechanism.
However, the lack of p44 interaction impacts not only XPD’s
helicase activity but also the recruitment of XPD to TFIIH,
thereby intensifying its phenotype [26]. All variants that fail to
separate dsDNA for the reasons explained above are also impaired
in NER. Our data thus show that it is essential for XPD to
maintain its capability to act as a classical helicase in NER and
that it is involved in unwinding the duplex around the lesion
promoting downstream processes that lead to a successful excision
(Figure 6). It is thus clear that the two helicase domains (HD1 and
HD2) are essential, but our data demonstrate that the investigated
FeS domain of XPD is also crucial for its enzymatic function and
subsequently for NER.
We utilized the available ‘‘molecular toolkit’’ of variants to
further dissect the involvement of XPD in transcription initiation
in a TFIIH and CAK context. To our great surprise, most of the
variants (C134S, C155S, Y158A, F161A, F193A, and R196A/E)
supported transcription in a wild-type–like manner (Figure 5).
However, it remains possible that transcription could be affected
in cells, perhaps at a subset of genes, because of auxiliary factors
whose activity or association with TFIIH is compromised by an
XPD mutation.
Our data demonstrate that none of the enzymatic properties of
XPD—namely, DNA binding, ATPase activity, and helicase
activity—are relevant for this process. Even the R196E/A variant,
which is highly impaired in DNA binding, has no impact on in
vitro transcription or CTD phosphorylation (Figures 2 and 5),
indicating that XPD does not interact with the DNA during
transcription. This observation is further supported by recent EM
structures from the PIC [45,46] in which XPD was modeled in
positions where it is not in close proximity to DNA. However, this
leads to the question of which function XPD is required to fulfill
during transcription, as its presence is undoubtedly important
[25,26,34]. This can be addressed with the phenotype of the
hsR722W variant, which does not support transcription. We show
that this variant is neither impaired in its tertiary structure nor in
DNA binding; hence, the lack of ATPase and helicase activity of
this variant must be explained by the loss of p44 interaction.
Taken together with the fact that the enzymatic activities of XPD
are obsolete in transcription, these observations suggest that the
decisive phenotype for transcription in this variant is exclusively
the lack of an interaction with p44.
This lack of interaction most likely results in a misplaced XPD
regarding the TFIIH composition and subsequently also the
displacement of the CAK complex, as XPD not only interacts with
the core-TFIIH subunit p44 but also provides the bridge to the
MAT1 subunit of the CAK complex via its Arch domain (Figure 1)
[32]. It has been shown that the interaction with CAK is not
interrupted in the hsR722W variant (Figure S3b) [26,32]; thus, the
lack of CTD phosphorylation and transcriptional activity in our
studies must be attributed to the wrong positioning of the CAK
complex caused by the impaired XPD/p44 interaction. This is
underlined by the observation that the hsR722W variant displays a
phenotype comparable to a TFIIH lacking XPD in its entirety and
cannot be rescued by increasing amounts of CAK (Figure 5d). The
data therefore suggest that the essential role of XPD during
transcription is to anchor the CAK to the core TFIIH and
consequently support its function within the PIC. The phenotype of
other TTD mutants strongly supports this hypothesis. From the X-
ray structures of XPD, it was speculated that mutations, which alter
the overall stability of XPD, exhibit a TTD phenotype. This
includes R112H, C259Y, R592P, and D673G of human XPD
[3,5,6]. C259Y is located in the Arch domain of XPD, and it was
recently shown that it influences the CAK interaction [32], thus
being the probable cause for the transcriptional defect of this
variant. We therefore propose that XPD only acts as a scaffold for
the structural integrity within the core TFIIH and is required for the
recruitment of other enzymatic factors like the CAK. When the
XPD/p44 interactions, on the one hand, and the XPD/MAT1
interactions, on the other hand, are permitted, XPD promotes
transcription, despite being completely inactive as an enzyme
(Figure 6). This is further supported by the phenotypes of the C134S
and C155S variants that presumably comprise an unfolded FeS
domain. Because the two major protein–protein interaction sites in
XPD reside in the C-terminal HD2 and in the Arch domain
(Figure 1), the FeS domain does not seem to be vital for either of
these interactions as these two variants still support transcription.
The observed reduced transcriptional activity is most likely due to
an overall effect on protein stability originating from the loss of a
folded FeS domain, as also proposed for the R112 TTD mutant
[2,4]. Thus, our data indicate that the FeS domain of XPD seems to
be uniquely dedicated to the helicase function in NER and is
dispensable for transcription. Intriguingly, the special role of the FeS
cluster for NER is further supported by other studies that link this
domain specifically to damage recognition [4,44,47,48].
In summary, our data demonstrate that the tasks of XPD within
transcription and repair are strikingly different. In NER, XPD has
to fulfill several roles by promoting protein–protein interactions
and acting as a helicase, whereas for transcription only the
protein–protein interactions are vital. In contrast to XPB, which
acts as an enzyme during NER and transcription, XPD does not
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assume a dual role as an enzyme (Figure 6). The enzyme XPD is
vital for NER, whereas for transcription only the intact ‘‘shell’’ of
XPD is sufficient.
Moreover, the present data allow the design of a TFIIH variant
that is solely active in transcription, with repair being abrogated.
In this aspect, it will be tempting to design an animal model with
such a mutation that would certainly represent a pure form of XP
and would be greatly useful for a better analysis of the disease
itself. Moreover, in cancer research, this represents an ideal model
for drug design.
Materials and Methods
Mutagenesis, Expression, and Purification of ctXPD,
ctp44, and ctMAT1
The gene encoding full-length ctXPD, ctp44 (1–285), and
ctMAT1 (1–248) were cloned from a cDNA library from C.
thermophilum (provided by Ed Hurt). ctXPD and ctp44 were
cloned in pETM11 (EMBL-Heidelberg). CtXPD mutants were
generated using the Quick-Change site-directed mutagenesis
kit (Stratagene). The reactions were carried out as suggested by
the manufacturer’s instructions. All mutants were verified by
double-stranded sequencing. CtXPD wild type, the variants,
and p44 were expressed as N-terminally His-tagged proteins in
Escherichia coli BL21-CodonPlus (DE3)-RIL cells (Stratagene)
by induction with 0.1 mM isopropyl-b-thiogalactoside at 14uC
for 18 h. The proteins were purified to homogeneity by metal
affinity chromatography (Ni-NTA, Invitrogen) followed by
anion exchange chromatography (AEC) in the case of ctXPD
or by SEC where indicated. AEC was performed using a
MonoQ 5/50 GL column (GE Healthcare) with 50 mM
NaPO4 pH 7.5, 1 M NaCl, and 1 mM TCEP as elution
buffer. The final buffer after AEC was NaPO4 pH 7.5,
200 mM NaCl, and 1 mM TCEP. SEC was performed using
a HiLoad 26/60 Superdex 200 prep grade column (GE
Healthcare) in 20 mM Tris-HCl or HEPES (pH 8.0), 200 mM
NaCl, and 1 mM TCEP. The proteins were concentrated to
5 mg/ml based on their calculated extinction coefficient using
ProtParam (SwissProt) and then flash frozen for storage. In the
case of ctMAT1, recombinant expression of the N-terminally
thioredoxin-His-tagged fusion protein was carried out in E.
coli BL21(DE3) star (Invitrogen) pRARE2 cells (Novagen) in
TB-medium, supplemented with 50 mg/ml Zinc acetate, by
addition of 0.3 mM IPTG for 16 h at 18uC. The protein was
purified by IMAC (Ni-IDA, Macherey-Nagel) and dialyzed
overnight in the presence of HRV-14 3C protease against
20 mM Hepes pH 8.0, 0.8 M NaCl, and 7 mM ß-Mercapto-
ethanol. SEC was performed as outlined above.
Figure 6. Model of the different XPD and XPB functionalities in NER and transcription. (a) In NER, XPD and XPB act as enzymes and have
to mediate protein–protein interactions. XPD [3,27,29] and XPB [30,31,50] are shown as a cartoon with their molecular surface. The other subunits are
depicted schematically. (b) As in (a), with the exception that the cartoon for XPD has been omitted and XPD is shown in green to exemplify that only
the ‘‘shell’’ of XPD is needed for transcription.
doi:10.1371/journal.pbio.1001954.g006
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ssDNA ctXPD Biolayer Interferometry Binding Assay
Real-time binding assays between ssDNA (59-gactacgtactgt-
tacggctccatctctaccgcaatcaggccagatctgc-39) and purified ctXPD
wild type, variants, and ctp44 were performed using biolayer
interferometry on an Octet RED system (Fortebio, Menlo Park,
CA). This system monitors interference of light reflected from the
surface of a fiber optic sensor to measure the thickness of
molecules bound to the sensor surface. The 39-biotinolyted DNA
was obtained from Biomers and coupled to kinetics grade
streptavidin biosensors (Fortebio, Menlo Park, CA) at a concen-
tration of 100 nM. Sensors coated with ssDNA were allowed to
bind ctXPD in reaction buffer (20 mM Tris-HCl pH 8.0,
150 mM NaCl, 10 mM MgCl2, 1 mM DTT, and 1 mg/ml
BSA) at different ctXPD concentrations ranging from 0.5 to 5 mM.
If ctp44 was added, it was always added using a molar ratio of 1:1
with respect to ctXPD. Measurements were carried out in
triplicates and with different protein batches. Binding kinetics
were calculated using the Octet Data Analysis Software 6.3, with a
1:1 binding model, to calculate the association rate constants.
Binding affinities were calculated as the ratio of dissociation and
association rate constants.
In Vitro ATPase Assay
CtXPD ATPase activity was measured with an in vitro ATPase
assay in which ATP consumption is coupled to the oxidation of
NADH via pyruvate kinase and lactate dehydrogenase activities.
Activities were measured at 37uC in 100 ml solution, containing
1.5 U pyruvate kinase, 1.9 U lactate dehydrogenase, 2 mM
phosphoenolpyruvate, and 0.15 mM NADH, 10 mM KCl,
1 mM MgCl2, 1 mM TCEP, and 20 mM Tris-HCl (pH 8.0).
ssDNA (59-gctcgagtctagactgcagttgagagcttgctaggacggatccctcgagg-
39) was added at a final concentration of 2 mM. The assay was
carried out under saturating concentrations of ATP (2 mM) using
ctXPD wild type and variants at a concentration of 500 nM with
ctp44 in a 1:2 stoichiometric ratio as indicated. Prior to the
analysis, ctXPD was heated to 50uC. For catalytic measurements,
the mix of all reagents, with the exception of ATP, was
preincubated at 37uC until a stable base line was achieved.
Enzyme catalysis was initiated by the addition of ATP. The
activity profiles were measured at 340 nm using a Floustar Optima
plate reader. Initial velocities were recorded and ATP consump-
tion was determined using the molar extinction coefficient of
NADH. The measurements were carried out in triplicates and
with at least two different protein batches.
In Vitro Helicase Assay
Helicase activity was analyzed utilizing a fluorescence-based
helicase assay [8,37]. We used a 59 overhang substrate with a cy3
label at the 39 end of the translocated strand (59-agctaccatgcctg-
cacgaattaagcaattcgtaatcatggtcatagct-39-cy3) and a dabcyl modifi-
cation on the 59 end of the opposite strand (Dabcyl-59-
agctatgaccatgattacgaatt-39). This results in a quenching of the
cy3 fluorescence that is removed upon unwinding of the substrate.
Assays were carried out in 20 mM Tris-HCl pH 8.0, 10 mM KCl,
1 mM MgCl2, and 1 mM TCEP. ctXPD wild type and variants
were used at a concentration of 500 nM, with concentrations of
ctp44 in a 1:2 molar ratio where indicated. Prior to the analysis,
ctXPD was heated to 50uC. The proteins were mixed with 40 nM
open fork substrate and 250 nM capture oligonucleotide (59-
caattcgtaatcatggtc-39). The reaction was subsequently started with
the addition of 2 mM ATP. Kinetics were recorded with a
Flouromax4 fluorescence spectrometer (Horiba Jobin Yvon) and
monitored until the reaction was completed, where possible.
Fluorescence was detected at an excitation wavelength of 550 nm
(slid width, 2 nm) and an emission wavelength of 570 nm (slid
width, 2 nm). Initial velocities were fitted with Origin8 and
represent the averages of at least two different reactions and two
independent protein batches.
Construction of Baculoviruses, Protein Production, and
Purification
The cDNAs encoding full-length hsXPD wild type and variants
(C134S, C155S, Y158A, F161A, F193A, R196A, R196E, L372A,
and R722) were cloned into pAC8F [11,12,49]. Resulting transfer
vectors were recombined with baculovirus DNA (BaculoGold
DNA, Pharmingen) in Sf9 cells to generate viruses for production
of hsXPD in fusion with the Flag peptide (DYKDDDDK).
For production of proteins and complexes, Sf21 cells were
infected/coinfected with the appropriate viruses/combinations of
viruses, collected 48 h postinfection, and purified as described [32],
Briefly, cells resuspended in buffer A (20 mM Tris–HCl, pH 8.0,
250 mM KCl, and 1 mM DTT) containing complete protease
inhibitor cocktail (Roche) were disrupted by sonication, and after
clarification, the lysate was incubated with protein A sepharose
beads cross-linked to the M2 anti-Flag antibody (SIGMATM) for
purification of XPD or CAK (both harbor an epitope FLAG) and to
the 1H5 anti-p44 antibody for purification of core-IIH. After
extensive washing in buffer A and equilibration in buffer B (50 mM
Tris-HCl pH 8.0, 75 mM KCl, 20% glycerol, 0.1% NP-40, and
1 mM DTT), proteins were eluted by competition with 2 CV of
buffer B containing the appropriate synthetic peptide at 0.5 mg/ml.
Protein concentrations were estimated by quantitative WB analysis
and adjusted to ,100 ng/ml. Monoclonal antibodies against the
human TFIIH subunits XPB (1B3), XPD (2F6), p52 (1D11), p44
(1H5), CDK7 (2F8), MAT1 (2D3), and p8 (1D1) were obtained
from IGBMC’s facilities.
Helicase and Dual Incision Assays
The 59-39 hsXPD helicase activity was analyzed using a mono-
directional strand displacement assay (for review, see [8,23]). The
probe was prepared by mixing an oligonucleotide (5 ng) corre-
sponding to nucleotides 6228–6251 of the single-stranded
M13mp18(+) DNA with single-stranded M13mp18(2) phage
(1 mg) in the presence of NaCl (25 mM) and MgCl2 (2.5 mM).
The mixture was heated for 2 min at 100uC and cooled slowly to
RT to allow annealing of the DNA heteroduplex. Probe labeling
was performed using the Klenow fragment in the presence of
dTTP (50 mM) and [a32P]dATP (70 mCi; 3,000 Ci/mmol;
Amersham). After phenol/chloroform extraction, the labeled
probe was purified using Micro Bio-Spin clean-up columns
(BioradTM).
Equivalent amounts of purified hsXPD wild type and variants
(,200 ng) were added to a 59-strand extension probe in the
presence of a 1.5 molar excess of p44 (,150 ng) to evaluate their
59–39 helicase activity. The reaction was performed for 45 min at
37uC by adding the immunopurified helicase to the DNA probe at
10 nM in 20 mM Tris-HCl (pH 8.0), 75 mM KCl, 4 mM MgCl2,
1 mM DTT, 4 mM ATP, and 0.1 mg/ml BSA with a total
reaction volume of 25 ml. The reaction was stopped by adding
20 mM EDTA, 14% glycerol, 0.2% SDS, and 0.028% bromo-
phenol to the reaction mixture. Analyses were performed by
migration in a 14% polyacrylamide gel (acrylamide/bis-acrylam-
ide ratio, 33/1) and autoradiography.
NER dual incision assays were performed as described [20–
22,26] using a plasmid with a single 1,3-intrastrand d(GpTpG)
(30 ng) in a buffer containing 50 mM Hepes-KOH (pH 7.8),
5 mM MgCl2, 1 mM DTT, 0.3 mM EDTA, 10% glycerol,
2.5 mg BSA, 50 mM KCl, and 2 mM ATP. Reaction mixes
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(25 ml) containing human XPG (5 ng), XPF/ERCC1 (15 ng),
XPC/hHR23B (10 ng), RPA (50 ng), XPA (25 ng), as well as a
mixture of purified core-IIH (250 ng) and XPD (100 and 200 ng)
were assembled to reconstitute TFIIH activity. Mixes were
incubated at 30uC for 90 min and analyzed as previously
described.
Dual-Luciferase Reporter Assay
The pGL3-SV40 vector expressing the FireFly luciferase under
the control of the SV40 promoter was UV irradiated (254 nm,
1,000 J/m2) at a concentration of 100 ng/ml in 10 mM Tris-HCl
(pH 8.0) and 1 mM EDTA. HD2 fibroblasts were seeded in
DMEM/HAM-F10 containing 10% FCS and 10 mg/ml gentam-
cin in a 24-well plate (50,000 cells/well). After 20 h, each well was
co-transfected using JetPEI (Polyplus) with 450 ng pGL3-SV40
(UV+/), 100 ng of pRL-TK expressing Renilla luciferase under
the control of the thymidine kinase promoter to normalize
transfection efficiencies, and 25 ng of pIRES2-EGFP derivatives
for expression of hsXPD wild type or variants under the control of
the CMV promoter and 450 ng of pBS. The medium was
exchanged after 3 h and further incubated for 36 h. Cell lysates
were prepared and activities were assayed using the Dual-Glo
Luciferase assay system (Promega).
In Vitro Transcription and Phosphorylation Assays
Run-off transcription assays were performed as described
[12,24,25] except that TFIIH was substituted by a mixture of
purified core-IIH, CAK, and XPD, which allowed us to prepare a
pre-mix containing all components with the exception of the XPD
variants. Reaction mixes contained the adenovirus major late
promoter sequence (AdMLP) EcoRI–SalI DNA template (75 ng),
TFIIB (15 ng), TFIIE (160 ng), TFIIF (500 ng of the phenyl
fraction from Pol II and the GTF purification scheme), TBP
(30 ng), endogenous RNAP II (10 mg of the 1 M DEAE fraction),
and a mixture of the purified core-IIH, CAK, and XPD. RNAP II
phosphorylation was carried out as a classical runoff transcription
except that ATP was added to a final concentration of 5 mM, and
the amount of purified RNAP II polymerase was adjusted
(typically reduced by a factor of 3). Hypo (IIA) and hyper (IIO)
phosphorylated forms of RNAP II were resolved on a 6% SDS-
PAGE and detected by Western blot using the monoclonal
antibody (7C2) directed against the CTD.
Supporting Information
Figure S1 Human and ctXPD. (a) Sequence alignment of
human and ctXPD. Identical residues are shown in white with a
red background. The different variants are indicated with a blue
dot and labeled; every 10th residue is marked by a small black dot.
Residues marked in red surrounded by a blue box are not strictly
conserved but indicate similar residues in close proximity that were
not captured by the sequence alignment. (b) Structure of taXPD
and the location of the different variants depicted as cpk models.
The schematic representation of the C terminus of eukaryotic
XPD that interacts with p44 is shown as dark red oval.
(TIF)
Figure S2 Stability analysis of ctXPD and its variants.
(a) Coomassie stained gel of ctXPD wild type and its variants.
Only the C133S variant proved to be less stable than the wild-type
protein during purification. (b) CD spectroscopy of ctXDP and its
variants. The analysis by CD spectroscopy clearly shows that all
the XPD variants assume the same fold as the wild-type protein. (c)
SEC of different ctXPD variants in the presence of p44. Each
variant is indicated in the chromatograms. XPD and p44 were
individually analyzed and are shown in blue and pink, respectively,
whereas the complex analysis is shown in red.
(TIF)
Figure S3 Interaction of XPD, p44, and MAT1. (a) Native
PAGE analysis of ctXPD and its variants showing the interaction
between ctXPD and ctMAT1. The different protein samples are
indicated above the respective lanes. Native PAGE analysis was
carried out using 6% Tris-glycine gels pH 8.1, and 500 nM wild-
type ctXPD (or the indicated variant) were incubated with
equimolar amounts of ctMAT1. The second band present in the
ctMAT1 sample has been identified by mass spectroscopy as a
degradation product of ctMAT1 lacking the N-terminal RING
domain of MAT1(1–83). (b and c) Pairwise interactions between
hsXPD variants and hsCAK or hsp44. Purified wild-type or
mutated human XPD variants were mixed with CAK or p44 in a
buffer containing 150 mM NaCl, 0.1% Nonidet P-40, 1 mM
DTT, 50 mM Tris/HCl at pH 8, and incubated for 4 h at 4uC in
the presence of anti-XPD antibody cross-linked to Protein A
agarose beads (5 ml per experiment). After extensive washing,
immunoprecipitated complexes were resolved by SDS/PAGE
with 12% (wt/vol) polyacrylamide and detected by Western blot
using anti-Cdk7, anti-cyclin H, or anti-p44 monoclonal antibodies.
The asterisks indicate the antibody light (LH) and heavy chains
(HC).
(TIF)
Figure S4 Time-dependent transcriptional activity of
hsXPD and selected variants. Recombinant wild-type and
mutant C134S, R722W, and K48R XPD variants (,100 ng) were
mixed with purified core-TFIIH (rIIH6) (250 ng) and CAK
(300 ng) and added to an in vitro reconstituted transcription
system containing all the basal transcription factors and the
adenovirus major late promoter sequence (AdMLP) EcoRI–SalI
DNA template (lanes 1–15). Following 10, 20, and 45 min
incubation at 30uC (lanes 2–14), transcripts were analyzed by
electrophoresis followed by autoradiography. A transcription
experiment performed with endogenous TFIIH was included as
a control (lane 15). 32P-labelled pBR322/Msp1 digests were used
as size markers (lane 16). The data used to generate the lower
panel have been deposited as supplementary information in xls
format (Table S4).
(TIF)
Table S1 Contains data for Figure 2.
(XLSX)
Table S2 Contains data for Figure 3.
(XLSX)
Table S3 Contains data for Figure 4.
(XLSX)
Table S4 Contains data for Figure S4.
(XLSX)
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